Review of Insulin Therapy In Type 2 Diabetes Mellitus Ambulatory Patients

Budi Suprapti, Nia Widyasari, Mahardian Rahmadi, Cahyo Wibisono


The purposes of this study were to review utilization of insulin therapy in type 2 diabetes mellitus out patients and identify its drug related problems. The data were collected cross-sectionally with purposive sampling method in the period March 2016 until May 2016 in Outpatient Clinic Universitas Airlangga Teaching Hospital Surabaya. The results of 240 patients showed that insulin was used as monotherapy insulin in 2,9% patients; combination 1 insulin & 1-4 OAD in 31,3%; basal bolus therapy 27,9%; combination basal−bolus therapy & 1-3 OAD 43,9%. Based on blood glucose target achievement, only 20,8% of patients achieve the target, 75,1% failed to achieve the target and 4,1%   suffered from hypoglycemia. Drug related problems identified adverse drug reaction of antidiabetic therapy such as hypoglycemia (6.7%), nausea (3.8%), bloating (1.3%), increase of flatulency (2.9%) and inappropriate combination (0,4%). In conclusion insulin therapy was complicated and individually, most of the patients still did not reach the target and there was potential drug related problem in this patients group. So that caring from solid inter-professional health collaboration is needed


Diabetes mellitus, insulin, ambulatory patient, DUR, DRP

Full Text:



American Diabetes Association., 2015. Standards of Medical Care in Diabetes: Volume 38 Suplement 1: S1-S83

Barret, Kim E., Barman, Susan M, Boitano, Scott and Brooks, Heddwen L. 2012. Ganong’s Review of Medical Physiology. 24th Edition. New York: The McGraw-Hill Companies.

Bennett, K., Bhandari., 2015. An overview of diabetic nephropathy: Epidemiology, pathophysiology and treatment. Journal of Diabetes Nursing. Volume 19. No. 2. Pp. 61-67

Bloomgarden, T, Zachary., 2004. Type 2 Diabetes in the Young: The envolving epidemic. Diabetes Care. Volume 27, No. 4. pp. 998

Boucher, J., Kleinridders, A., Kahn, C. Ronald., 2014. Insulin Receptor Signaling in Normal and Insulin-Resistant States. Harvard Medical School

CDC. 2015. Distribution of Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18-79 Years. Centers for Disease Control and Prevention

Funk, J.L. 2014. Disorder of The Endocrine Pancreas. In: McPhee.S. J; Hammer G.D. (Eds.), Pathophysiology of Disease an Introduction to Clinical Medicine. 7th ed. : New York : Mc Graw Hill

Harper, W., Clement, M., Goldenberg, R., Hanna, A., Main, A., Retnakaran, R., Sherifali, D., Woo, V., Francois, J., 2013. Pharmacologic Management of Type 2 Diabetes. Canadian Journal of Diabetes. 37(2013): S61-S68

Hundal, R.S., Inzucchi, S.E., 2003. Metformin: New Understandings, New Uses. Leading Article. pp 1800-1889

IDF Diabetes Atlas. 2013. International Diabetes Federation 6th ed. pp: 19-99

Inzucchi, S, E., Bergenstal, R.M., Ferrannini, E., Nauck, M., Peters, A.L., Tsapas, A., Wender, R., Matthews, D.R., 2015. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient Center Approach. Diabetes Care 2015; 38: 140-149

Ismail, F., 2004. Current Management of Type 2 Diabetes: Why Thiazolidinediones Should Be the Cornerstone of Therapy. The Journal of Applied Research. Volume. 4, No 3.

Kennedy & Masharani. 2012. Pancreatic Hormones and Antidiabetic Drugs. In: Basic and Clinical Pharmacology. 12th Edition. New York: The McGraw-Hill Companies, p. 743-765.

Kirkman M.S., Jones, V.B., Clark, N., Florez, H., Haas, L.B., Halter, J.B., Huang, E.S., Korytkowski, M.T., Munshi, M.N., Odegard, P.S., Pratley, R.E., Swift, C.S., 2012. Diabetes in Older Adults. Diabetes Care, Volume 35. pp. 2650-2655

Kroon & Williams. 2013. Endocrine Disorders. In: Koda-Kimble & Young’s (Eds.). Applied Therapeutics the Clinical Use of Drugs.10th ed. Wolters Kluwer Health: Lippincott Williams & Wilkins.

Kyung, B.K., Roh, E., Seul, Y.Y., Kyong, M.M., 2016. Difference between old and young adults in contribution of β-cell function and sarcopenia in developing diabetes mellitus. Original Article: Journal of Diabetes Investigation, Volume 7, No.2, pp 233-238

Massi, M.B., Orsini, M.F., 2008. Treatment of Type 2 Diabetes with Combined Therapy. Diabetes Care, Volume 31, Supplement 2.

Meneghini, L.F., 2009. Early Insulin Treatment in Type 2 Diabetes. Diabetes Care. Volume 32. Supplement 2: S266-S269

Nathan, D.M. Buse, J.B. Davidson, M. B; Ferrannini, E. Holman, R.R., Sherwin., R; Zinman, B., 2009. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the initiation and Adjustment of Therapy, Vol 32. No.1. pp 193-203

Ndraha S. 2014. Medicinus : Diabetes Melitus Tipe 2 dan TataLaksana Terkini Vol 27 No.2 . Jakarta

PERKENI. 2011. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia. Pengurus Besar Perkumpulan Endokrinologi Indonesia.

Pranoto, A., 2011. Insulin Therapy for Type 2 Diabetes Early Insulination: Rationale & Evidence. Pusat Diabetes & amp

Pranoto A. 2012. Terapi Insulin: Pada Penderita Diabetes Melitus Rawat Jalan dan Rawat Inap. Surabaya: Airlangga University Press.

Raccah D., Bretzel, R.G., Owens D., Riddle, M., 2007. When basal insulin therapy in type 2 diabetes mellitus is not enough-what next? Diabetes Metab Res Rev 23(4):257-264

RISKESDAS., 2013. Riset Kesehatan Dasar, Jakarta: Balitbang Kementerian Kesehatan Republik Indonesia.

Rismayanthi Cerika. 2010. Medikora : Terapi Insulin Sebagai Alternatif Pengobatan Bagi Penderita Diabetes : Vol VI, No. 2. Yogyakarta

Schwinghammer T.L. 2015. Endocrinologic Disorders. In: Dipiro, J. T. Pharmacotherapy: A Pathophysiologic Approach. 7th Ed.: New York, McGraw-Hill Medical. pp 155- 175.

Soewondo P., Soegondo S., Suastika K., Pranoto A., Soeatmadji D.W., Tjokroprawiro A. 2010. The DiabCare Asia 2008 study – Outcomes on control and complications of type 2 diabetic patients in Indonesia Vol.19, No 4.

Suastika K., Soeatmadji D.W., Asdie., Adam MF., Soegondo S., Manaf A., Pandelaki K., Sukran A., Soewondo P., Soebagijo A., Sambo A., Yunir Em., Saraswati R., 2011 Petunjuk Praktis Terapi Insulin. pp. 1-35

Tanwani L.K. 2011. Insulin Therapy in the Elderly Patient with Diabetes. The American Journal of Geriatric Pharmacotherapy. Louisville, Kentucky. pp 24-33.

Tanyolac, S., Goldfine, I.D. & Kroon, L. 2010. Insulin-Pharmacology, Types of Regimens, and Adjusment. San Fransisco: University of California.

Umpierrez, G., Smiley, D., Zisman, A., Prieto, L.M., Palacio, A., Ceron, M., Puig, A., Mejia, R., 2007. Original Article: Randomized Study of Basal−Bolus Insulin Therapy in the Inpatient Management of Patient with Type 2 Diabetes (Rabbit 2 Trial). Diabetes Care. Volume 30, No. 9, pp. 2181-2185

World Health Organization. 2016. Diabetes World Health Organization. Geneva: World Health Organization



  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats